Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts

Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]

PDF) Effectiveness and safety of adalimumab in patients with

Full article: POSTER PRESENTATIONS

The state of the art—psoriatic arthritis outcome assessment in

Impact of tapering targeted therapies (bDMARDs or JAKis) on the

Impact of Achieving Minimal Disease Activity on Patient-Reported

ACR23 SpA Research for the SAA Spondyloarthritis Community - My

Endorsement of Definitions of Disease Activity States and

Frontiers Targeted Therapies in Axial Psoriatic Arthritis

Impact of tapering targeted therapies (bDMARDs or JAKis) on the

Plenary Presentations - 2021 - International Journal of Rheumatic

The Ankylosing Spondylitis Disease Activity Score (ASDAS) is the

Real-world effectiveness of golimumab in adult patients with

Expert Perspective: Management of the Psoriatic Arthritis Patient

Assessment and Monitoring, Ankylosing Spondylitis